Physician profile
James C Carr
NPI 1376504183
$91,713.14
in general payments reported to CMS, 2019-2025
6 companies · $29K in 2025
The $29K reported for 2025 was more than what 99% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2021: $1,000 · 2022: $13K · 2023: $20K · 2024: $10K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $49K · Consulting Fee: $8,024 · Food and Beverage: $1,319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $49,160.57 |
| Consulting Fee | $8,024.00 |
| Food and Beverage | $1,318.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $57,937.23 | 2019-2025 | Magnetom Free.Max, Biograph Mmr, Naeotom Alpha |
| Bayer Healthcare Pharmaceuticals INC. | $14,979.66 | 2019-2022 | |
| Philips North America LLC | $10,554.74 | 2023-2025 | Ri Prof Svcs |
| Bayer Healthcare LLC | $8,174.00 | 2025 | |
| Canon Medical Systems USA, INC. | $67.51 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.